Medicine & Life Sciences
Annexin A2
100%
Annexins
90%
Trastuzumab
80%
ErbB Receptors
64%
Breast Neoplasms
43%
Small Interfering RNA
18%
Cell Movement
18%
Cell Survival
17%
Down-Regulation
15%
Triple Negative Breast Neoplasms
13%
Membranes
13%
Receptor Protein-Tyrosine Kinases
12%
Endocytosis
11%
Carcinogenesis
8%
Up-Regulation
8%
Ligands
7%
RNA
7%
Cell Proliferation
7%
Apoptosis
6%
Cell Line
6%
Survival
6%
Proteins
4%
Therapeutics
3%
Agriculture & Biology
epidermal growth factor receptors
90%
breast neoplasms
77%
small interfering RNA
31%
receptors
18%
endocytosis
15%
cell movement
14%
carcinogenesis
14%
cell viability
12%
apoptosis
12%
tyrosine
12%
ligands
12%
cell proliferation
12%
phosphotransferases (kinases)
11%
therapeutics
10%
viability
10%
cell lines
10%
RNA
8%
cells
8%
sampling
4%
proteins
4%
Chemical Compounds
Silencing RNA
35%
Cell Viability
13%
Tyrosine
12%
Ligand
5%
Protein
5%